Navigation Links
Einstein researchers devise a fast and sensitive way to detect ricin
Date:4/8/2009

April 8, 2009 (BRONX, NY) Scientists at Albert Einstein College of Medicine of Yeshiva University have developed a simple, accurate, and highly sensitive test to detect and quantify ricin, an extremely potent toxin with potential use as a bioterrorism agent. The report appears as a featured article in the April 12th issue of Analytical Chemistry.

Ricin, a protein extracted from castor beans, can be in the form of a powder, mist, pellet or solution. When injected or inhaled, as little as one-half milligram of ricin is lethal to humans. No antidote is available. The most infamous ricin attack occurred in London in 1978, when Bulgarian dissident Georgi Markov died after being stabbed with an umbrella that injected a ricin-coated pellet into his leg.

The ricin assay described in the journal article was developed in the laboratory of Vern Schramm, Ph.D., professor and Ruth Merns Chair of Biochemistry at Einstein and corresponding author. The assay detects small amounts of ricin more accurately and faster than ever before.

Users of the assay would place samples of potentially adulterated food, or swabs used to wipe potentially contaminated surfaces, into a few drops of a mixture of reagents; the mixture will emit light if ricin is present, with higher luminescence indicating greater concentrations of the toxin.

Dr. Schramm believes the assay's most immediate application is for discovering drugs that could serve as antidotes for ricin poisoning.

"Previously we had to rely on laborious, multi-step methods to see if a compound was preventing ricin from working, which is probably why no antidote to ricin has yet been discovered," explained Dr. Schramm.

After ricin enters cells, it kills them by interfering with their ability to make proteins─a basic cellular function. Ricin does this by disrupting ribosomal RNA (the key component of ribosomes, the cell's protein manufacturing "machines"). The ricin attack causes ribosomal RNA to release a molecule of adenine. Dr. Schramm's assay detects and quantifies ricin by measuring the amount of adenine released by cells.

"Our lab's expertise is in enzymes," says Dr. Schramm. "One day I realized we could use a specific enzyme to convert the adenine released by ricin into ATP─a molecule whose presence can be easily detected by an already-available assay based on the light-emitting gene from fireflies. In retrospect, like many scientific advances, it's such a simple idea that I'm surprised it wasn't thought of earlier."

Ricin has also been used as an anticancer agent by linking it to antibodies that home to tumors and deliver the ricin 'warhead' to kill cancer cells. Einstein scientists indicate that detection of ricin in cancer trials may be an early use of this technology. While the researchers emphasize that the ricin detection method is now laboratory-based, they also predict that relatively minor changes will be needed to make detection of ricin by light practical for field and clinical applications.

Albert Einstein College of Medicine has filed a patent application on the ricin detection method and is interested in licensing the technology to a company or organization that would develop it further for drug discovery and public health applications.


'/>"/>

Contact: Chris Iannantuoni
ciannant@aecom.yu.edu
718-430-8806
Albert Einstein College of Medicine
Source:Eurekalert

Related biology news :

1. NIH funds research center for womens reproductive health at Einstein
2. Einstein and Pitt researchers develop new TB test that will dramatically cut diagnosis time
3. Empire State Stem Cell Board awards $12.7 million to Albert Einstein College of Medicine
4. Einstein scientists receive $10 million NIH grant
5. Einstein researchers develop technique to count messages made by single genes
6. Einstein researchers develop a new way to study how breast cancer spreads
7. In scientific first, Einstein researchers correct decline in organ function associated with old age
8. Feinstein researchers develop new genetic method and identify novel genes for schizophrenia
9. Einstein researchers receive grants totaling $700,000 for innovative breast cancer research
10. Einstein researcher receives NIH grant to explore epigenetic regulation of the human genome
11. NC State researchers find soy may aid in treating canine cancers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/9/2016)... ISTANBUL , June 9, 2016  Perkotek an innovation leader in attendance control ... to seamlessly log work hours, for employers to make sure the right employees are ... Logo - http://photos.prnewswire.com/prnh/20160609/377486LOGO ... ... ...
(Date:6/2/2016)... 2016 The Department of Transport Management ... 44 million US Dollar project, for the , ... Personalization, Enrolment, and IT Infrastructure , to ... and implementation of Identity Management Solutions. Numerous renowned international vendors ... Decatur was selected for the most compliant and ...
(Date:5/24/2016)... 2016 Ampronix facilitates superior patient care by providing unparalleled technology to leaders ... is the latest premium product recently added to the range of products distributed by ... ... ... LCD Medical Display- Ampronix News ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... June 23, 2016 ... 2016;12(1):22-8 http://doi.org/10.17925/OHR.2016.12.01.22 Published recently ... peer-reviewed journal from touchONCOLOGY, Andrew D Zelenetz ... of cancer care is placing an increasing burden ... expensive biologic therapies. With the patents on many ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... line of intelligent tools designed, tuned and optimized exclusively for Okuma CNC machining ... Chicago. The result of a collaboration among several companies with expertise in toolholding, ...
(Date:6/22/2016)... DUBLIN , June 22, 2016 Research ... and Global Markets" report to their offering. ... $39.4 billion in 2014 from $29.3 billion in 2013. The market ... (CAGR) of 13.8% from 2015 to 2020, increasing from $50.6 billion ... and projected product forecasts during the forecast period (2015 to 2020) ...
(Date:6/22/2016)... SAN DIEGO , June 22, 2016   ... the first pluripotent stem cell-derived islet replacement therapy for ... two presentations at ISSCR 2016 Annual Meeting.  ISSCR 2016, ... 22nd to 25th at Moscone West in San Francisco.  ... Details of the presentations are as follows:Event: , Focus ...
Breaking Biology Technology: